Key Findings
The global intragastric balloon market is projected to register a CAGR of 12.14%, during the forecast period of 2019 to 2028. The market growth is driven by factors such as a vast obese population, a rise in government initiatives, short hospital stays, and quicker recovery time post intragastric ballooning, and an unhealthy lifestyle.

Market Insights
The intragastric balloon is a device-based bariatric procedure that entails the implantation of a silicone balloon, filled with air or saline. By limiting food intake, the balloon functions as a temporary method of facilitating weight loss for 6-12 months. Since this procedure is a very simple method, it does not require surgery. Lifestyle plays a vital role in establishing the health of an individual, daily life, and behavioral factors influence weight. Primary health concerns associated with present lifestyles are unhealthy dietary intake, lack of physical activity, and smoking. These factors have resulted in obesity and being overweight. Also, as per a new study report, over 2 billion adults and children worldwide are overweight or obese and, suffer from health problems resulting from their weight. As a result, the additional fat in the body affects cell functioning, which leads to complications like cardiovascular disease, diabetes mellitus, and stroke. Thus, these factors are projected to stimulate global intragastric market growth.

Regional Insights
The geographical segmentation and analysis of the global intragastric balloon market comprise North America, Asia Pacific, Europe, and the rest of the world. The North America region is estimated to garner the largest market share, and the Asia Pacific region is lined up to record the highest CAGR throughout the forecast period. The prevalence of obesity combined with related health conditions like diabetes and hypertension is expected to contribute to market growth in the Asia Pacific region.

Competitive Insights
There exists a moderate to high competition between manufacturers, as market players are established. Some of the leading companies in the market are Allurion Technologies Inc, Apollo Endosurgery Inc, Aspire Bariatrics Inc, Allegran Inc, Baronova Inc, etc.
Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments